Chatham Capital Group’s United Therapeutics UTHR Stock Holding History

Chatham Capital Group’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,994	Closed	-$2.16M	–	193
2021 Q4	$2.16M	Buy	9,994 +15	+0.2%	+$2.94K	0.39%	69
2021 Q3	$1.85M	Sell	9,979 -198	-2%	-$39K	0.36%	74
2021 Q2	$1.83M	Buy	10,177 +1	+0%	+$190	0.35%	76
2021 Q1	$1.7M	Buy	10,176 +185	+2%	+$30.8K	0.36%	80
2020 Q4	$1.52M	Sell	9,991 -60	-0.6%	-$7.87K	0.34%	79
2020 Q3	$1.01M	Sell	10,051 -40	-0.4%	-$4.39K	0.25%	88
2020 Q2	$1.22M	Buy	10,091 +46	+0.5%	+$5.18K	0.32%	80
2020 Q1	$953K	Sell	10,045 -35	-0.3%	-$3.33K	0.28%	83
2019 Q4	$888K	Sell	10,080 -85	-0.8%	-$7.48K	0.22%	100
2019 Q3	$811K	Sell	10,165 -170	-2%	-$13.7K	0.21%	104
2019 Q2	$807K	Buy	10,335 +71	+0.7%	+$6.64K	0.2%	100
2019 Q1	$1.21M	Buy	10,264 +74	+0.7%	+$8.62K	0.31%	85
2018 Q4	$1.11M	Buy	10,190 +900	+10%	+$104K	0.31%	81
2018 Q3	$1.19M	Hold	9,290	–	–	0.3%	79
2018 Q2	$1.05M	Buy	9,290 +200	+2%	+$22K	0.28%	80
2018 Q1	$1.02M	Sell	9,090 -600	-6%	-$76.2K	0.27%	78
2017 Q4	$1.43M	Buy	9,690 +80	+0.8%	+$10.2K	0.39%	57
2017 Q3	$1.13M	Hold	9,610	–	–	0.32%	70
2017 Q2	$1.25M	Buy	9,610 +618	+7%	+$77.1K	0.35%	60
2017 Q1	$1.22M	Sell	8,992 -1,018	-10%	-$154K	0.34%	63
2016 Q4	$1.44M	Buy	10,010 +1,800	+22%	+$230K	0.42%	57
2016 Q3	$969K	Sell	8,210 -400	-5%	-$48.1K	0.31%	68
2016 Q2	$912K	Buy	8,610 +100	+1%	+$11.2K	0.28%	70
2016 Q1	$948K	Buy	8,510 +200	+2%	+$25.3K	0.3%	69
2015 Q4	$1.3M	Hold	8,310	–	–	0.42%	51
2015 Q3	$1.09M	Sell	8,310 -400	-5%	-$64.2K	0.37%	52
2015 Q2	$1.51M	Hold	8,710	–	–	0.43%	52
2015 Q1	$1.5M	Buy	8,710 +150	+2%	+$22.9K	0.44%	48
2014 Q4	$1.11M	Hold	8,560	–	–	0.33%	62
2014 Q3	$1.1M	Buy	8,560 +100	+1%	+$10.3K	0.34%	57
2014 Q2	$749K	Hold	8,460	–	–	0.29%	72
2014 Q1	$795K	Hold	8,460	–	–	0.33%	68
2013 Q4	$957K	Sell	8,460 -150	-2%	-$13.5K	0.4%	53
2013 Q3	$679K	Hold	8,610	–	–	0.31%	72
2013 Q2	$567K	Buy	+8,610	New	+$555K	0.28%	77